2020
DOI: 10.1111/ncn3.12426
|View full text |Cite
|
Sign up to set email alerts
|

Thrombolytic therapy in ischemic stroke patients with a preceding transient ischemic attack in telestroke and non‐telestroke settings

Abstract: Background This study investigates the risk factors associated with exclusion or inclusion for thrombolytic therapy in TIA‐ischemic stroke patients in a telestroke compared with a non‐telestroke setting. Methods This study retrospectively analyzes regional stroke data collected between January 2010 and June 2016 from TIA‐ischemic stroke patients. We used the logistic regression model to predict clinical risk factors associated with exclusion or inclusion for thrombolytic therapy in the telestroke and non‐teles… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
13
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 30 publications
(71 reference statements)
1
13
0
Order By: Relevance
“…Serum HDL-c has antiatherogenic properties that allow flow of cholesterol to liver from peripheral cells, providing a defensive outcome [22]. Poupore et al discovered elevated LDL and higher lipoprotein levels in ischemic stroke patients compared to dyslipidemia trends in ischemic stroke patients [23]. They found that hypertension (74.3 %), hyperglycemia (64 %), and dyslipidemia (57.1 %), were the common risk factors and their findings on dyslipidemia were similar to ours.…”
Section: Discussionsupporting
confidence: 73%
“…Serum HDL-c has antiatherogenic properties that allow flow of cholesterol to liver from peripheral cells, providing a defensive outcome [22]. Poupore et al discovered elevated LDL and higher lipoprotein levels in ischemic stroke patients compared to dyslipidemia trends in ischemic stroke patients [23]. They found that hypertension (74.3 %), hyperglycemia (64 %), and dyslipidemia (57.1 %), were the common risk factors and their findings on dyslipidemia were similar to ours.…”
Section: Discussionsupporting
confidence: 73%
“…[ 69 ] Possible adverse events that have been associated with statin therapy are myopathy and hemorrhagic stroke. [ 23 ] Therefore, a more accurate understanding of the effectiveness and safety of different statins can be helpful in reducing a gender-specific higher total cholesterol. Therefore, understanding the different factors that impact men and women stroke populations is vital to promoting gender specific changes and this study is a step that provides information that can result in improved and better outcomes for patients.…”
Section: Discussionmentioning
confidence: 99%
“…This is because early admission is known to reduce poor outcome compared with 48 hours. [ 22 , 23 ] Data on patients with a suspicion of subarachnoid hemorrhage through CT findings (ICH, SAH, or other major infarct signs) was considered as a contraindication, and patients in this category were excluded. Demographics, clinical characteristics, laboratory values, and other pertinent data were obtained from a stroke registry; this registry has been described in previous studies.…”
Section: Methodsmentioning
confidence: 99%
“…[ 9 10 ] Other models including modified Rankin score and Barthel's index try to quantify functional outcomes of stroke recovery,[ 11 48 49 ] but none of these tests specifically measure motor recovery. [ 18 50 ] Our finding that changes in ambulatory outcome were associated with higher NIHSS scores and worsening neurologic outcome reveals that ambulatory function may serve as a significant quantitative measure and predictor of future outcomes following an anterior stroke in AIS patients with OSA. [ 27 ]…”
Section: Discussionmentioning
confidence: 99%
“…[ 46 47 48 ] This is because direct admission has been shown to reduce the door-to-needle time to <60 min in >70% of AIS patients and to <50 min in >45% of AIS patients. [ 49 50 51 ] Such a time improvement could be helpful when implementing the protocol of mixing and administering rtPA thrombolytic therapy to stroke patients, resulting in timely intervention that could lead to improved neurologic outcome.…”
Section: Discussionmentioning
confidence: 99%